ResMed Inc. vs Global X Robo Global Robotics & Automation ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Global X Robo Global Robotics & Automation ETF trades at $79.51. The key difference: ResMed Inc. pays a 1.21% dividend while Global X Robo Global Robotics & Automation ETF pays none, and Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | ROBO | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Sector/Thematic |
52-Week High | $293.73 | $90.34 |
52-Week Low | $182.82 | $61.34 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ROBO Global Robotics and Automation Index ETF trades at $77.31, down 0.74% with a bearish technical signal from moving averages. The ETF provides diversified exposure to robotics and AI themes with 79 holdings across machinery and electronic equipment sectors. Recent index rebalancing has shifted weight toward AI infrastructure and physical automation themes, reflecting evolving technology trends.
The ETF offers growth exposure to the expanding physical AI ecosystem but faces cyclical risks from industrial markets. While thematic positioning remains relevant, valuation concerns exist with a 24.9x P/E ratio. Key catalysts include AI infrastructure development and reshoring trends, though competition and market volatility present ongoing challenges.
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →